Patient psychological well-being was affected even in survivors diagnosed with stage 0.

Patients who suffer from localized cutaneous melanoma report high levels of fear of cancer recurrence, according to a new analysis. 

Researchers investigating the psychological well-being and fear of cancer recurrence among survivors of localized cutaneous melanoma in the United States evaluated participants using semistructured interviews, as well as a survey tool called the Fear of Cancer Recurrence Inventory short form (FCRI-SF). The study's 51 participants, aged on average 49.5 years, with a history of stage 0-IIA melanoma, were recruited from an academic dermatology practice in Texas.

According to the results, participants reported various themes, including emotions surrounding follow-up appointments, the intensity of melanoma surveillance, lifestyle changes related to sun exposure, and contemplation on life and death. Notably, despite the favorable prognosis associated with localized melanoma, 38 out of 51 participants exhibited clinically significant fear of cancer recurrence based on their FCRI-SF scores, suggesting notable impact on their psychological well-being.

"These findings suggest that despite having excellent prognoses, survivors of localized melanoma have high rates of fear of cancer recurrence, and express intense negative survivorship experiences that could affect psychological well-being," the authors wrote. 

The study, according to the research team, underscores the intense survivorship experiences of individuals with localized melanoma, even those diagnosed with stage 0, and highlighted the importance of addressing their psychological needs.

Source: Mahama AN, Haller CN, Labrada J, et al. Lived Experiences and Fear of Cancer Recurrence Among Survivors of Localized Cutaneous Melanoma. JAMA Dermatology. Published online February 14, 2024. doi:https://doi.org/10.1001/jamadermatol.2023.6158